Opportunity cost

BMJ

Volumn 318, Issue 7197, 1999, Pages 1551-

  Palmer, Stephen ^a   Raftery, James ^b  

^a UNIVERSITY OF YORK   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85007734397     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.318.7197.1551     Document Type: Article

References (9)

1. Gold Mr, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996.
2. Russell LB. Opportunity costs in modern medicine. Health Affairs 1992; 11: 162–169.
3. Byford S, Raftery J. Perspectives in economic evaluation. BMJ 1998; 316: 1529.
4. Torgerson DJ, Spencer A. Marginal costs and benefits. BMJ 1996; 307: 726–728.
5. Robinson R. Costs and cost-minimisation analysis. BMJ 1993; 307: 726–728.
6. Dawson D. Costs and prices in the internal market: markets versus the NHS Management Executive guidelines. York: Centre for Health Economics, University of York, 1994.
7. Stiglitz JE. Economics of the public sector. New York: Norton, 1986.
8. Posnett J, Jan S. Indirect cost in economic evaluation: the opportunity cost of unpaid inputs. Health Economics 1996; 5: 13–23.
9. Koopmanschapp MA, Rutten FH. A practical guide for calculating indirect costs of disease. Pharmacoeconomics 1996; 10: 460–466.